Loading...

Jamie Resnik

Title(s)Clinical Professor, Reproductive Medicine
SchoolHealth Sciences
Phone858-249-1204
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Resnik JL. What Is New in Contraception?: Best Articles From the Past Year. Obstet Gynecol. 2019 May; 133(5):1052-1054. PMID: 30969222.
      View in: PubMed
    2. Resnik JL. What Is New in Health Disparities?: Best Articles From the Past Year. Obstet Gynecol. 2018 04; 131(4):734-736. PMID: 29528936.
      View in: PubMed
    3. Ecker JL, Kaimal A, Mercer BM, Blackwell SC, deRegnier RA, Farrell RM, Grobman WA, Resnik JL, Sciscione AC. Periviable birth: Interim update. Am J Obstet Gynecol. 2016 Aug; 215(2):B2-B12.e1. PMID: 27103153.
      View in: PubMed
    4. Ecker JL, Kaimal A, Mercer BM, Blackwell SC, deRegnier RA, Farrell RM, Grobman WA, Resnik JL, Sciscione AC. #3: Periviable birth. Am J Obstet Gynecol. 2015 Nov; 213(5):604-14. PMID: 26506448.
      View in: PubMed
    5. Chapman J, Miles PD, Ofrecio JM, Neels JG, Yu JG, Resnik JL, Wilkes J, Talukdar S, Thapar D, Johnson K, Sears DD. Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS One. 2010 Nov 12; 5(11):e13959. PMID: 21103061.
      View in: PubMed
    6. Hsiao G, Chapman J, Ofrecio JM, Wilkes J, Resnik JL, Thapar D, Subramaniam S, Sears DD. Multi-tissue, selective PPAR? modulation of insulin sensitivity and metabolic pathways in obese rats. Am J Physiol Endocrinol Metab. 2011 Jan; 300(1):E164-74. PMID: 20959535.
      View in: PubMed
    7. Resnik JL, Hong C, Resnik R, Kazanegra R, Beede J, Bhalla V, Maisel A. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol. 2005 Aug; 193(2):450-4. PMID: 16098869.
      View in: PubMed
    8. Hupfeld CJ, Resnik JL, Ugi S, Olefsky JM. Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors. J Biol Chem. 2005 Jan 14; 280(2):1016-23. PMID: 15520010.
      View in: PubMed
    9. Resnik JL, Reichart DB, Huey K, Webster NJ, Seely BL. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res. 1998 Mar 15; 58(6):1159-64. PMID: 9515800.
      View in: PubMed
    10. Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res. 1996 Jun 15; 56(12):2781-8. PMID: 8665514.
      View in: PubMed
    11. Webster NJ, Kong Y, Cameron KE, Resnik JL. An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes. 1994 Feb; 43(2):305-12. PMID: 8288055.
      View in: PubMed
    12. Cameron KE, Resnik J, Webster NJ. Transcriptional regulation of the human insulin receptor promoter. J Biol Chem. 1992 Aug 25; 267(24):17375-83. PMID: 1324934.
      View in: PubMed